Flotillins in receptor tyrosine kinase signaling and cancer

Cells

Volumn 3, Issue 1, 2014, Pages 129-149

  Banning, Antje ^a,b   Kurrle, Nina ^a   Meister, Melanie ^a   Tikkanen, Ritva ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

Author keywords

Cancer; Diabetes; Flotillins; Insulin; Metastasis; Mitogen activated proteins kinase; Receptor tyrosine kinases

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR; FLOTILLIN 1; FLOTILLIN 2; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL KINASE; PROTEIN TYROSINE KINASE; PROTEINASE ACTIVATED RECEPTOR 1; RETINOID RELATED ORPHAN RECEPTOR ALPHA;

APOPTOSIS; BREAST CANCER; CANCER PROGNOSIS; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; ENDOCYTOSIS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; MELANOMA; METASTASIS; NEOPLASM; NERVE FIBER GROWTH; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 84903789654     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3010129     Document Type: Review

References (95)

1. Banning, A.; Tomasovic, A.; Tikkanen, R. Functional aspects of membrane association of reggie/flotillin proteins. Curr. Protein Pept. Sci. 2011, 12, 725-735.
2. Kurrle, N.; John, B.; Meister, M.; Tikkanen, R. Function of Flotillins in Receptor Tyrosine Kinase Signaling and Endocytosis: Role of Tyrosine Phosphorylation and Oligomerization. In Protein Phosphorylation in Human Health; Huang, C., Ed.; InTech Publisher: Rijeka, Croatia, 2012.
3. Ramos, J.W. The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells. Int. J. Biochem. Cell Biol. 2008, 40, 2707-2719.
4. Kim, E.K.; Choi, E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2010, 1802, 396-405.
5. Schubbert, S.; Shannon, K.; Bollag, G. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 2007, 7, 295-308.
6. Wan, P.T.; Garnett, M.J.; Roe, S.M.; Lee, S.; Niculescu-Duvaz, D.; Good, V.M.; Jones, C.M.; Marshall, C.J.; Springer, C.J.; Barford, D.; et al Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 2004, 116, 855-867.
7. Normanno, N.; De Luca, A.; Bianco, C.; Strizzi, L.; Mancino, M.; Maiello, M.R.; Carotenuto, A.; De Feo, G.; Caponigro, F.; Salomon, D.S. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene 2006, 366, 2-16.
8. Schulte, T.; Paschke, K.A.; Laessing, U.; Lottspeich, F.; Stuermer, C.A. Reggie-1 and reggie-2, two cell surface proteins expressed by retinal ganglion cells during axon regeneration. Development 1997, 124, 577-587.
9. Bickel, P.E.; Scherer, P.E.; Schnitzer, J.E.; Oh, P.; Lisanti, M.P.; Lodish, H.F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. J. Biol. Chem.1997, 272, 13793-13802.
10. Edgar, A.J.; Polak, J.M. Flotillin-1: gene structure: cDNA cloning from human lung and the identification of alternative polyadenylation signals. Int. J. Biochem. Cell Biol. 2001, 33, 53-64.
11. Rivera-Milla, E.; Stuermer, C.A.; Malaga-Trillo, E. Ancient origin of reggie (flotillin), reggielike, and other lipid-raft proteins: convergent evolution of the SPFH domain. Cell. Mol. Life Sci 2006, 63, 343-357.
12. Malaga-Trillo, E.; Laessing, U.; Lang, D.M.; Meyer, A.; Stuermer, C.A. Evolution of duplicated reggie genes in zebrafish and goldfish. J. Mol. Evol. 2002, 54, 235-245.
13. Browman, D.T.; Hoegg, M.B.; Robbins, S.M. The SPFH domain-containing proteins: more than lipid raft markers. Trends Cell Biol. 2007, 17, 394-402.
14. Tavernarakis, N.; Driscoll, M.; Kyrpides, N.C. The SPFH domain: implicated in regulating targeted protein turnover in stomatins and other membrane-associated proteins. Trends Biochem. Sci. 1999, 24, 425-427.
15. Salzer, U.; Prohaska, R. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 2001, 97, 1141-1143.
16. Snyers, L.; Umlauf, E.; Prohaska, R. Oligomeric nature of the integral membrane protein stomatin. J. Biol. Chem.1998, 273, 17221-17226.
17. Huber, T.B.; Simons, M.; Hartleben, B.; Sernetz, L.; Schmidts, M.; Gundlach, E.; Saleem, M.A.; Walz, G.; Benzing, T. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum. Mol. Genet. 2003, 12, 3397-3405.
18. Tatsuta, T.; Model, K.; Langer, T. Formation of membrane-bound ring complexes by prohibitins in mitochondria. Mol. Biol. Cell 2005, 16, 248-259.
19. Babuke, T.; Ruonala, M.; Meister, M.; Amaddii, M.; Genzler, C.; Esposito, A.; Tikkanen, R. Hetero-oligomerization of reggie-1/flotillin-2 and reggie-2/flotillin-1 is required for their endocytosis. Cell. Signalling 2009, 21, 1287-1297.
20. Solis, G.P.; Hoegg, M.; Munderloh, C.; Schrock, Y.; Malaga-Trillo, E.; Rivera-Milla, E.; Stuermer, C.A. Reggie/flotillin proteins are organized into stable tetramers in membrane microdomains. Biochem. J. 2007, 403, 313-322.
21. Neumann-Giesen, C.; Falkenbach, B.; Beicht, P.; Claasen, S.; Luers, G.; Stuermer, C.A.; Herzog, V.; Tikkanen, R. Membrane and raft association of reggie-1/flotillin-2: role of myristoylation, palmitoylation and oligomerization and induction of filopodia by overexpression. Biochem. J. 2004, 378, 509-518.
22. Amaddii, M.; Meister, M.; Banning, A.; Tomasovic, A.; Mooz, J.; Rajalingam, K.; Tikkanen, R. Flotillin-1/reggie-2 plays a dual role in the activation of receptor tyrosine kinase/map kinase signaling. J. Biol. Chem.2012, 287, 7265-7278.
23. Banning, A.; Regenbrecht, C.R.; Tikkanen, R. Increased activity of mitogen activated protein kinase pathway in flotillin-2 knockout mouse model. Cell. Signalling 2014, 26, 198-207.
24. Volonte, D.; Galbiati, F.; Li, S.; Nishiyama, K.; Okamoto, T.; Lisanti, M.P. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J. Biol. Chem. 1999, 274, 12702-12709.
25. Fernow, I.; Icking, A.; Tikkanen, R. Reggie-1 and reggie-2 localize in non-caveolar rafts in epithelial cells: cellular localization is not dependent on the expression of caveolin proteins. Eur. J. Cell Biol. 2007, 86, 345-352.
26. Glebov, O.O.; Bright, N.A.; Nichols, B.J. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nat. Cell Biol. 2006, 8, 46-54.
27. Simons, K.; Gerl, M.J. Revitalizing membrane rafts: new tools and insights. Nat. Rev. Mol. Cell Biol. 2010, 11, 688-699.
28. Morrow, I.C.; Rea, S.; Martin, S.; Prior, I.A.; Prohaska, R.; Hancock, J.F.; James, D.E.; Parton, R.G. Flotillin-1/reggie-2 traffics to surface raft domains via a novel golgi-independent pathway. Identification of a novel membrane targeting domain and a role for palmitoylation. J. Biol. Chem. 2002, 277, 48834-48841.
29. Liu, J.; Deyoung, S.M.; Zhang, M.; Dold, L.H.; Saltiel, A.R. The stomatin/prohibitin/flotillin/HflK/C domain of flotillin-1 contains distinct sequences that direct plasma membrane localization and protein interactions in 3T3-L1 adipocytes. J. Biol. Chem. 2005, 280, 16125-16134.
30. Neumann-Giesen, C.; Fernow, I.; Amaddii, M.; Tikkanen, R. Role of EGF-induced tyrosine phosphorylation of reggie-1/flotillin-2 in cell spreading and signaling to the actin cytoskeleton. J. Cell Sci. 2007, 120, 395-406.
31. Riento, K.; Frick, M.; Schafer, I.; Nichols, B.J. Endocytosis of flotillin-1 and flotillin-2 is regulated by Fyn kinase. J. Cell Sci. 2009, 122, 912-918.
32. Banning, A.; Ockenga, W.; Finger, F.; Siebrasse, P.; Tikkanen, R. Transcriptional regulation of flotillins by the extracellularly regulated kinases and retinoid X receptor complexes. PLoS one 2012, 7, e45514.
33. Stuermer, C.A.; Lang, D.M.; Kirsch, F.; Wiechers, M.; Deininger, S.O.; Plattner, H. Glycosylphosphatidyl inositol-anchored proteins and fyn kinase assemble in noncaveolar plasma membrane microdomains defined by reggie-1 and-2. Mol. Biol. Cell 2001, 12, 3031-3045.
34. de Gassart, A.; Geminard, C.; Fevrier, B.; Raposo, G.; Vidal, M. Lipid raft-associated protein sorting in exosomes. Blood 2003, 102, 4336-4344.
35. Strauss, K.; Goebel, C.; Runz, H.; Mobius, W.; Weiss, S.; Feussner, I.; Simons, M.; Schneider, A. Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease. J. Biol. Chem. 2010, 285, 26279-26288.
36. Gkantiragas, I.; Brugger, B.; Stuven, E.; Kaloyanova, D.; Li, X.Y.; Lohr, K.; Lottspeich, F.; Wieland, F.T.; Helms, J.B. Sphingomyelin-enriched microdomains at the Golgi complex. Mol. Biol. Cell 2001, 12, 1819-1833.
37. Santamaria, A.; Fernandez, P.L.; Farre, X.; Benedit, P.; Reventos, J.; Morote, J.; Paciucci, R.; Thomson, T.M. PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. Am. J. Pathol. 2003, 162, 897-905.
38. Ha, H.; Kwak, H.B.; Lee, S.K.; Na, D.S.; Rudd, C.E.; Lee, Z.H.; Kim, H.H. Membrane rafts play a crucial role in receptor activator of nuclear factor kappaB signaling and osteoclast function. J. Biol. Chem. 2003, 278, 18573-18580.
39. Berger, T.; Ueda, T.; Arpaia, E.; Chio, C., II; Shirdel, E.A.; Jurisica, I.; Hamada, K.; You-Ten, A.; Haight, J.; Wakeham, A.; et al Flotillin-2 deficiency leads to reduced lung metastases in a mouse breast cancer model. Oncogene 2013, 32, 4989-4994.
40. Ludwig, A.; Otto, G.P.; Riento, K.; Hams, E.; Fallon, P.G.; Nichols, B.J. Flotillin microdomains interact with the cortical cytoskeleton to control uropod formation and neutrophil recruitment. J. Cell. Biol. 2010, 191, 771-781.
41. Kato, N.; Nakanishi, M.; Hirashima, N. Flotillin-1 regulates IgE receptor-mediated signaling in rat basophilic leukemia (RBL-2H3) cells. J. Immunol. 2006, 177, 147-154.
42. Solis, G.P.; Schrock, Y.; Hulsbusch, N.; Wiechers, M.; Plattner, H.; Stuermer, C.A. Reggies/flotillins regulate E-cadherin-mediated cell contact formation by affecting EGFR trafficking. Mol. Biol. Cell. 2012, 23, 1812-1825.
43. Meister, M.; Tomasovic, A.; Banning, A.; Tikkanen, R. Mitogen-activated protein (MAP) kinase scaffolding proteins: a recount. Int. J. Mol. Sci. 2013, 14, 4854-4884.
44. Kurrle, N.; Ockenga, W.; Meister, M.; Vollner, F.; Kuhne, S.; John, B.A.; Banning, A.; Tikkanen, R. Phosphatidylinositol 3-Kinase dependent up-regulation of the epidermal growth factor receptor upon Flotillin-1 depletion in breast cancer cells. BMC Cancer 2013, 13, 575.
45. Eswarakumar, V.P.; Lax, I.; Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16, 139-149.
46. Dixon, S.J.; MacDonald, J.I.; Robinson, K.N.; Kubu, C.J.; Meakin, S.O. Trk receptor binding and neurotrophin/fibroblast growth factor (FGF)-dependent activation of the FGF receptor substrate (FRS)-3. Biochim. Biophys. Acta 2006, 1763, 366-380.
47. Hadari, Y.R.; Gotoh, N.; Kouhara, H.; Lax, I.; Schlessinger, J. Critical role for the dockingprotein FRS2 alpha in FGF receptor-mediated signal transduction pathways. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 8578-8583.
48. Xu, H.; Lee, K.W.; Goldfarb, M. Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins. J. Biol. Chem.1998, 273, 17987-17990.
49. Gotoh, N. Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins. Cancer Sci 2008, 99, 1319-1325.
50. Kouhara, H.; Hadari, Y.R.; Spivak-Kroizman, T.; Schilling, J.; Bar-Sagi, D.; Lax, I.; Schlessinger, J. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 1997, 89, 693-702.
51. Tomasovic, A.; Traub, S.; Tikkanen, R. Molecular networks in FGF signaling: flotillin-1 and cblassociated protein compete for the binding to fibroblast growth factor receptor substrate 2. PLoS One 2012, 7, e29739.
52. Ong, S.H.; Guy, G.R.; Hadari, Y.R.; Laks, S.; Gotoh, N.; Schlessinger, J.; Lax, I. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors. Mol. Cell. Biol. 2000, 20, 979-989.
53. Limpert, A.S.; Karlo, J.C.; Landreth, G.E. Nerve growth factor stimulates the concentration of TrkA within lipid rafts and extracellular signal-regulated kinase activation through c-Cblassociated protein. Mol. Cell. Biol. 2007, 27, 5686-5698.
54. Kimura, A.; Baumann, C.A.; Chiang, S.H.; Saltiel, A.R. The sorbin homology domain: a motif for the targeting of proteins to lipid rafts. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 9098-9103.
55. Melillo, R.M.; Santoro, M.; Ong, S.H.; Billaud, M.; Fusco, A.; Hadari, Y.R.; Schlessinger, J.; Lax, I. Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol. Cell Biol. 2001, 21, 4177-4187.
56. Degoutin, J.; Vigny, M.; Gouzi, J.Y. ALK activation induces Shc and FRS2 recruitment: Signaling and phenotypic outcomes in PC12 cells differentiation. FEBS Lett. 2007, 581, 727-734.
57. Wu, Y.; Chen, Z.; Ullrich, A. EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2. Biol. Chem. 2003, 384, 1215-1226.
58. Kurokawa, K.; Iwashita, T.; Murakami, H.; Hayashi, H.; Kawai, K.; Takahashi, M. Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 2001, 20, 1929-1938.
59. Stoletov, K.V.; Ratcliffe, K.E.; Terman, B.I. Fibroblast growth factor receptor substrate 2 participates in vascular endothelial growth factor-induced signaling. Faseb J. 2002, 16, 1283-1285.
60. Baumann, C.A.; Ribon, V.; Kanzaki, M.; Thurmond, D.C.; Mora, S.; Shigematsu, S.; Bickel, P.E.; Pessin, J.E.; Saltiel, A.R. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407, 202-207.
61. Ahn, M.Y.; Katsanakis, K.D.; Bheda, F.; Pillay, T.S. Primary and essential role of the adaptor protein APS for recruitment of both c-Cbl and its associated protein CAP in insulin signaling. J. Biol. Chem. 2004, 279, 21526-21532.
62. Ribon, V.; Saltiel, A.R. Insulin stimulates tyrosine phosphorylation of the proto-oncogene product of c-Cbl in 3T3-L1 adipocytes. Biochem. J. 1997, 324, 839-845.
63. Chiang, S.H.; Baumann, C.A.; Kanzaki, M.; Thurmond, D.C.; Watson, R.T.; Neudauer, C.L.; Macara, I.G.; Pessin, J.E.; Saltiel, A.R. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 2001, 410, 944-948.
64. Fecchi, K.; Volonte, D.; Hezel, M.P.; Schmeck, K.; Galbiati, F. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J. 2006, 20, 705-707.
65. Delahaye, L.; Rocchi, S.; Van Obberghen, E. Potential involvement of FRS2 in insulin signaling. Endocrinology 2000, 141, 621-628.
66. Sugawara, Y.; Nishii, H.; Takahashi, T.; Yamauchi, J.; Mizuno, N.; Tago, K.; Itoh, H. The lipid raft proteins flotillins/reggies interact with Galphaq and are involved in Gq-mediated p38 mitogen-activated protein kinase activation through tyrosine kinase. Cell. Signalling 2007, 19, 1301-1308.
67. Yamauchi, J.; Nagao, M.; Kaziro, Y.; Itoh, H. Activation of p38 mitogen-activated protein kinase by signaling through G protein-coupled receptors. Involvement of Gbetagamma and Galphaq/11 subunits. J. Biol. Chem. 1997, 272, 27771-27777.
68. Rajendran, L.; Beckmann, J.; Magenau, A.; Boneberg, E.M.; Gaus, K.; Viola, A.; Giebel, B.; Illges, H. Flotillins are involved in the polarization of primitive and mature hematopoietic cells. PLoS One 2009, 4, e8290.
69. Rossy, J.; Schlicht, D.; Engelhardt, B.; Niggli, V. Flotillins interact with PSGL-1 in neutrophils and, upon stimulation, rapidly organize into membrane domains subsequently accumulating in the uropod. PLoS One 2009, 4, e5403.
70. Affentranger, S.; Martinelli, S.; Hahn, J.; Rossy, J.; Niggli, V. Dynamic reorganization of flotillins in chemokine-stimulated human T-lymphocytes. BMC Cell Biol. 2011, 12, 28.
71. Fais, S.; Malorni, W. Leukocyte uropod formation and membrane/cytoskeleton linkage in immune interactions. J. Leukoc. Biol. 2003, 73, 556-563.
72. Zhang, S.H.; Wang, C.J.; Shi, L.; Li, X.H.; Zhou, J.; Song, L.B.; Liao, W.T. High Expression of FLOT1 Is Associated with Progression and Poor Prognosis in Hepatocellular Carcinoma. PLoS One 2013, 8, e64709.
73. Song, L.; Gong, H.; Lin, C.; Wang, C.; Liu, L.; Wu, J.; Li, M.; Li, J. Flotillin-1 promotes tumor necrosis factor-alpha receptor signaling and activation of NF-kappaB in esophageal squamous cell carcinoma cells. Gastroenterology 2012, 143, 995-1005. e12.
74. Lin, C.; Wu, Z.; Lin, X.; Yu, C.; Shi, T.; Zeng, Y.; Wang, X.; Li, J.; Song, L. Knockdown of FLOT1 impairs cell proliferation and tumorigenicity in breast cancer through up-regulation of FOXO3a. Clin. Cancer Res. 2011, 17, 3089-3099.
75. Zhu, Z.; Wang, J.; Sun, Z.; Sun, X.; Wang, Z.; Xu, H. Flotillin2 expression correlates with HER2 levels and poor prognosis in gastric cancer. PLoS One 2013, 8, e62365.
76. Pust, S.; Klokk, T.I.; Musa, N.; Jenstad, M.; Risberg, B.; Erikstein, B.; Tcatchoff, L.; Liestol, K.; Danielsen, H.E.; van Deurs, B.; Sandvig, K. Flotillins as regulators of ErbB2 levels in breast cancer. Oncogene 2013, 32, 3443-3451.
77. Wang, X.; Yang, Q.; Guo, L.; Li, X.H.; Zhao, X.H.; Song, L.B.; Lin, H.X. Flotillin-2 is associated with breast cancer progression and poor survival outcomes. J. Transl. Med. 2013, 11, 190.
78. Hazarika, P.; McCarty, M.F.; Prieto, V.G.; George, S.; Babu, D.; Koul, D.; Bar-Eli, M.; Duvic, M. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res. 2004, 64, 7361-7369.
79. Doherty, S.D.; Prieto, V.G.; George, S.; Hazarika, P.; Duvic, M. High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res. 2006, 16, 461-463.
80. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA: Cancer J. Clin. 2011, 61, 69-90.
81. Perou, C.M.; Sorlie, T.; Eisen, M.B.; van de Rijn, M.; Jeffrey, S.S.; Rees, C.A.; Pollack, J.R.; Ross, D.T.; Johnsen, H.; Akslen, L.A.; et al Molecular portraits of human breast tumours. Nature 2000, 406, 747-752.
82. Slamon, D.J.; Godolphin, W.; Jones, L.A.; Holt, J.A.; Wong, S.G.; Keith, D.E.; Levin, W.J.; Stuart, S.G.; Udove, J.; Ullrich, A.; et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 1989, 244, 707-712.
83. Slamon, D.J.; Clark, G.M.; Wong, S.G.; Levin, W.J.; Ullrich, A.; McGuire, W.L. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235, 177-182.
84. Baselga, J.; Swain, S.M. Novel anticancer targets: Revisiting ERBB2 and discovering ERBB3. Nat. Rev. Cancer 2009, 9, 463-475.
85. Yarden, Y.; Pines, G. The ERBB network: At last, cancer therapy meets systems biology. Nat. Rev. Cancer 2012, 12, 553-563.
86. Yarden, Y.; Sliwkowski, M.X. Untangling the ErbB signalling network. Nat. Rev. Mol. Cell Biol. 2001, 2, 127-137.
87. Citri, A.; Kochupurakkal, B.S.; Yarden, Y. The achilles heel of ErbB-2/HER2: regulation by the Hsp90 chaperone machine and potential for pharmacological intervention. Cell Cycle 2004, 3, 51-60.
88. Citri, A.; Gan, J.; Mosesson, Y.; Vereb, G.; Szollosi, J.; Yarden, Y. Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation. EMBO Rep. 2004, 5, 1165-1170.
89. Subik, K.; Lee, J.F.; Baxter, L.; Strzepek, T.; Costello, D.; Crowley, P.; Xing, L.; Hung, M.C.; Bonfiglio, T.; Hicks, D.G.; Tang, P. The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines. Breast Cancer 2010, 4, 35-41.
90. COSMIC catalogue of somatic mutations in cancer. Available online: http://cancer.sanger.ac.uk/cosmic (accessed on 12 December 2013).
91. Verschraegen, C.F.; Giovanella, B.C.; Mendoza, J.T.; Kozielski, A.J.; Stehlin, J.S., Jr. Specific organ metastases of human melanoma cells injected into the arterial circulation of nude mice. Anticancer Res. 1991, 11, 529-535.
92. Chay, C.H.; Cooper, C.R.; Gendernalik, J.D.; Dhanasekaran, S.M.; Chinnaiyan, A.M.; Rubin, M.A.; Schmaier, A.H.; Pienta, K.J. A functional thrombin receptor (PAR1) is expressed on bonederived prostate cancer cell lines. Urology 2002, 60, 760-765.
93. Shi, X.; Gangadharan, B.; Brass, L.F.; Ruf, W.; Mueller, B.M. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol. Cancer Res. 2004, 2, 395-402.
94. Martinelli, S.; Chen, E.J.; Clarke, F.; Lyck, R.; Affentranger, S.; Burkhardt, J.K.; Niggli, V. Ezrin/Radixin/Moesin proteins and flotillins cooperate to promote uropod formation in T cells. Front. Immunol. 2013, 4, 84.
95. Li, L.; Luo, J.; Wang, B.; Wang, D.; Xie, X.; Yuan, L.; Guo, J.; Xi, S.; Gao, J.; Lin, X.; et al. Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer. Mol. Cancer 2013, 12, 163.